← All trials
NCT04798417
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 8, 2021
- Primary completion
- Jul 15, 2021
- Completion date
- Jul 15, 2021
- First posted
- Mar 15, 2021
- Last posted
- Jul 30, 2021
- Enrollment
- 180
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Wageningen UniversityLead sponsor
- Roquette FreresCollaborator
- Wageningen UniversityReponsible party - principal investigator
- Ingredion IncorporatedCollaborator
- Naturex SACollaborator
- Ingredia S.A.Collaborator
- Iberica Co. Ltd.Collaborator
- NexiraCollaborator
- Darling IngredientsCollaborator
- Winclove Bio Industries BVCollaborator
- WecareCollaborator
- Government of DenmarkCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.